Delivery Order SPE2DB25D3404-SPE2DB25FUQFA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,616.52 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count packages). This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive award to the established pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $1,152.00 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed price contract valued at $11,828.08. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, leveraging its...
- The Defense Logistics Agency awarded a $2,170.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical prime vendor agreement running through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,544.34 to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is classified as a child contract, indicating...
- The Defense Logistics Agency awarded a delivery order valued at $3,304.00 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This competitive, firm fixed-price delivery order was executed on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,604.78 delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be performed at the vendor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,258.40 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $35,436.35. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,152.00 to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under the...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUQFADelivery Order
The Defense Logistics Agency awarded a $4,101.48 delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a critical pharmaceutical distributor for federal medical procurement. This delivery order exemplifies AmerisourceBergen's role as a primary supplier within the DLA's global pharmaceutical support network, which provides medications and medical supplies to Defense Health Agency facilities, the U.S. Coast Guard, and other federal healthcare systems worldwide. As a child delivery order under the SPE2DX IDC, this award demonstrates the company's ongoing capability to fulfill routine pharmaceutical procurement requirements across multiple therapeutic domains, including hormone treatments such as progesterone for military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/5/25 |